Intendis and Dow Pharmaceutical Sciences Sues River’s Edge Pharmaceuticals
May 20, 2011
Intendis and Dow Pharmaceutical Sciences filed suit against River’s Edge Pharmaceuticals over a patent related to a topical low-viscosity gel composition. 5/18, District of New Jersey, 2:2011cv02838.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
